Stay updated with breaking news from Nuventra Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global Biosimulation Market, which was valued at around US$ 2.6 billion in 2021, is anticipated to grow at a CAGR of 21.5% during the ensuing ten years, reaching US$ 20.9 billion by the end of 2032. The necessity to develop novel pharmaceuticals to treat rising ailments will be what will fuel the demand for bios...
/PRNewswire/ -- The biosimulation market is to grow by USD 3,163.61 million from 2022 to 2027 and register a CAGR of 15.06%, according to Technavio's latest...
/PRNewswire/ -- The global Bio Simulation Market is projected to grow at a CAGR of 16.20% from 2023 to 2030, according to a new report published by Verified...
North America holds the largest market for biosimulation. The rising chronic disease among the population in the region and regulations implemented by the...
/PRNewswire/ -- The "Biosimulation Global Market Report 2022, By Product, Application, End User" report has been added to ResearchAndMarkets.com's offering....